Cost-effectiveness of etiologic diagnosis for C. trachomatis infection based on rapid tests versus syndromic approach in non-pregnant women with symptoms of lower genital tract infection
DOI:
https://doi.org/10.18597/rcog.33Keywords:
Cost-benefit analysis, cervicitis, ColombiaAbstract
Objective: To estimate the cost-effectiveness of etiological approach with rapid tests for C. trachomatis cervicitis versus syndromic diagnosis, in non-pregnant women with symptoms of lower genital tract infection in Colombia.
Materials and methods: A decision tree was developed for determining the cost-effectiveness ratio of the aetiological approach using the Acon®Plate, Acon®Duo and QuickVue® quick tests for the detection of C. trachomatis, compared with the syndromic diagnosis. The perspective was that of the Colombian healthcare system, including medical direct costs. The time period was 15 days, considering that the outcome unit was the number of cases identified correctly (number of true positives and true negatives). The operational characteristics of the tests were derived from a cross-sectional study designed and conducted for that specific purpose.
Results: The more costly and effective option was QuickVue®, followed by Acon®Plate and the syndromic approach. Acon®Duo was a dominated strategy. The incremental cost-effectiveness ratio for QuickVue® compared with Acon®Plate was $430.671, and that of Acon®Plate compared with the syndromic approach was $79.747.
Conclusion: If the willingness to pay (WTP) for an additional case that is correctly identified is greater than $430.671, QuickVue® would be the best option in cost-effectiveness terms. On the other hand, if the WTP is between $79.747 and $430.671, Acon®Plate would be the cost-effective strategy. Finally, if the WTP is less than $79.747, the syndromic approach would be the best option in cost-effectiveness terms.
Author Biographies
Víctor Prieto-Martínez
Alexander Moreno-Calderón
José Urrego-Novoa
Jorge Augusto Díaz-Rojas
Andrea Rodríguez-Hernández
Ariel Iván Ruiz-Parra
Instituto de Investigaciones Clínicas, Departamento de Obstetricia y Ginecología, Universidad Nacional de Colombia, Bogotá (Colombia).
Hernando Gaitán-Duarte
Jorge E. Tolosa-Ardila
References
World Health Organization. Sexually transmitted infections. Fact sheet. 2011 [Visitado 2014 ene 15]. Disponible en: http://www.who.int/mediacentre/factsheets/fs110/en/.
Stamm WE. Chlamydia trachomatis infections in the adult. En: Holmes KK, Sparling PF, Stamm WE, et al. (eds.). Sexually transmitted diseases. 4th edition. New York: McGraw-Hill; 2008. p. 595-606.
Centers for Disease Control and Prevention. Gonorrhea-CDC Fact Sheet (Detailed Version). Atlanta, GA: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. 2014 [Visitado 2014 ene 15]. Disponible en: http://www.cdc.gov/std/gonorrhea/STDFact-gonorrhea-detailed.htm.
Valderrama J, Zacarias F, Mazin R. Maternal syphilis and congenital syphilis in Latin America: big problem, simple solution. Rev Panam Salud Pública. 2004: 16:211-7.
Organización Mundial de la Salud. Guías para el tratamiento de las infecciones de transmisión sexual. 2005 [Visitado 2014 ene 15]. Disponible en: http://www.who.int/hiv/pub/sti/STIguidelines2003_es.pdf.
Ministerio de Salud y Protección Social de Colombia. Guía de Práctica Clínica para el abordaje sindrómico del diagnóstico y tratamiento de los pacientes con infecciones de transmisión sexual y otras infecciones del tracto genital. [Visitado 2014 oct 14]. Disponible en: http://gpc.minsalud.gov.co/Documents/Guias-PDF-Recursos/ITS/GPC_Prof_Sal_ITS.pdf.
Canadian Guidelines on Sexually Transmitted Infections. Ottawa: Public Health Agency of Canada. 2010 [Visitado 2014 ene 15]. Disponible en: http://www.phac-aspc.gc.ca/std-mts/sti-its/cgsti-ldcits/section-4-1-eng.php.
LeFevre ML. Screening for chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement. Ann Intern Med. 2014; 161:58-66 [Epub ahead of print].
Kamali A, Quigley M, Nakiyingi J, Kinsman J, Kengeya- Kayondo J, Gopal R, et al. Syndromic management of sexually-transmitted infections and behavior change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial. Lancet. 2003;36:645-52.
Peeling RW, Holmes KK, Mabey D, Ronald A. Rapid tests for sexually transmitted infections (STIs): the way forward. Sex Transm Infect. 2006;82:v1-6.
Ministerio de Salud y Protección Social. Resolución 005521 (octubre 27 de 2013). [Visitado 2014 ene 15]. Disponible en: http://www.minsalud.gov.co/sites/rid/Lists/BibliotecaDigital/RIDE/DE/DIJ/Resoluci%C3%B3n%205521%20de%202013.pdf.
Angel-Müller E, Rodríguez A, Núñez-Forero LM, Moyano LF, González P, Osorio E, et al. Prevalencia y factores asociados a la infección por C. trachomatis, N. gonorrheae, T. vaginalis, C. albicans, Sífilis, VIH y vaginosis bacteriana en mujeres con síntomas de infección vaginal en tres sitios de atención de Bogotá, Colombia, 2010. Rev Colomb Obstet Ginecol. 2012; 63:14-24.
Tolosa JE, Rodríguez AE, Müller EA, Ruiz-Parra AI, Núñez-forero L, Moyano LF, et al. Accuracy of syndromic diagnosis and management of vaginal discharge and cervicitis in women of reproductive age in Bogotá, Colombia. Int J Gynecol Obstet. 2012;119:S3-S729.
Núñez-Forero L, Moyano LF, Angel-Müller E, Rodríguez A, Ruiz-Parra AI, Tolosa JE, et al. Diagnostic accuracy of rapid tests for C. Trachomatis, N. Gonorrhoeae and Syphilis at the point of care in women with symptoms of lower genital tract infection Int J Gynecol Obstet. 2012;119:S3-S350.
Instituto de Evaluación Tecnológica en Salud. Manual para la elaboración de evaluaciones económicas en salud. Bogotá D.C.: IETS. 2014 [Visitado 2014 ago 11]. Disponible en: http://www.iets.org.co/Manuales/Manuales/Manual%20EyS%20%20web_30%20sep.pdf.
Canadian Agency for Drugs and Technologies in Health. Guidelines for the economic evaluation of health technologies. 3rd ed. Ottawa: CADTH. 2006 [Visitado 2012 nov 10]. Disponible en: http://www.cadth.ca/en/products/health-technology-assessment/publication/953.
Consejo Directivo del Instituto de Seguros Sociales. Acuerdo 256 de 2001, Por el cual se aprueba el "Manual de tarifas" de la Entidad Promotora de Salud del Seguro Social "EPS-ISS". 2001 [Visitado 2012 ene 14]. Disponible en: http://lexsaludcolombia.files.wordpress.com/2010/10/tarifas-iss-2001.pdf.
Detsky AS, Naglie G, Krahn MD, Naimark D, Redelmeier DA. Primer on medical decision analysis: Part 1--Getting started. Med Decis Making. 1997;17:123-5.
Sánchez-Pedraza R, Gamboa O, Díaz JA. Modelos empleados para la toma de decisiones en el cuidado de la salud. Rev Salud Pública. 2008;10:178-88.
Detsky AS, Naglie G, Krahn MD, Redelmeier DA, Naimark D. Primer on medical decision analysis: Part 2--Building a tree. Med Decis Making. 1997;17: 126-35.
Briggs A, Claxton K, Sculpher M. Decision modelling for health economic evaluation. Oxford University Press; 2006.
Briggs A, Gray A. Handling uncertainty when performing economic evaluation of healthcare interventions. Health Technol Assess. 1999;3:1-134.
Briggs A. Handling Uncertainty in Cost-Effectiveness Models. Pharmacoeconomics. 2000;17:479-500.
Redwood-Campbell L, Plumb J. The syndromic approach to treatment of sexually transmitted diseases in low-income countries: issues, challenges, and future directions. J Obstet Gynaecol Can. 2002;24:417-24.
Trollope-Kumar K, Guyatt G. Syndromic approach for treatment of STIs: time for a change. Lancet. 2006;367:1380-1.
Laking G, Lord J, Fischer A. The economics of diagnosis. Health Econ. 2006;15:1109-20.
Sanghera S, Orlando R, Roberts T. Economic evaluations and diagnostic testing: an illustrative case study approach. Int J Technol Assess Health Care. 2013;29:53-60.
Roberts TE, Robinson S, Barton P, Bryan S, Low N. Screening for Chlamydia trachomatis: a systematic review of the economic evaluations and modelling. Sex Transm Infect. 2006;82:193-200.
How to Cite
Downloads
Downloads
Published
Issue
Section
| Article metrics | |
|---|---|
| Abstract views | |
| Galley vies | |
| PDF Views | |
| HTML views | |
| Other views | |
